Effects of epidurally administered dexmedetomidine and dexamethasone on postoperative pain, analgesic requirements, inflammation, and oxidative stress in thoracic surgery
Acta Pharmaceutica · 01.12.2023 · 73 (4) · 691-708
DOI: 10.2478/acph-2023-0040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica, online erschienen am 26.12.2023. Verfasst von Jasminka Peršec und 7 weiteren Autor:innen. Beteiligte Einrichtung: 1Clinical Department for Anesthesiology Reanimatology and Intensive Care Medicine, University Hospital Dubrava Zagreb, Croatia. Hauptthemen laut MEDLINE: Dexmedetomidine, Thoracic Surgery. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Schmerzmanagement
Abstract (Originalsprache)
The aim of this study was to compare the effects of dexmedetomidine and dexamethasone as adjuvants to preoperative epidural administration of local anesthetic (ropivacaine) in thoracic surgery on the postoperative level of pain, use of analgesics, inflammation, and oxidative stress. The study enrolled 42 patients who underwent elective thoracic surgery in a one-year period at the University Hospital Dubrava (Zagreb, Croatia). Based on a computer-generated randomization list the patients were assigned to the dexmedetomidine ( n = 18) or dexamethasone ( n = 24) group. Postoperatively, patients of dexmedetomidine group reported lower pain (VAS value 1 h post surgery, 3.4 ± 2.7 vs. 5.4 ± 1.8, dexmedetomidine vs. dexamethasone, p < 0.01) and had lower anal-gesic requirements in comparison with dexamethasone group. Thus, dexmedetomidine in comparison with dexamethasone was more efficient in lowering pain and analgesia requirements 24 h after the surgery. On the contrary, dexamethasone had better anti-inflammatory properties (CRP level 24 h post surgery, 131.9 ± 90.7 vs. 26.0 ± 55.2 mg L −1 , dexmedetomidine vs. dexamethasone, p < 0.01). Both dexmedetomidine and dexamethasone exhibited antioxidant effects, however, their antioxidant properties should be further explored. The results of this study improve current knowledge of pain control in thoracic surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Clinical Department for Anesthesiology Reanimatology and Intensive Care Medicine, University Hospital Dubrava Zagreb, Croatia.
- 2School of Dental Medicine, University of Zagreb, Zagreb, Croatia.
- 3University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Pharmacology, Zagreb, Croatia.
- 4University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Biophysics, Zagreb, Croatia.
- 5University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Botany, Zagreb, Croatia.
ORCID-Profile: Ana-Marija Domijan
Zitieren
APA
Peršec, J., Šribar, A., Ilić, M., Mamić, I., Kifer, D., Domijan, A. M., Maleš, Ž., & Turčić, P. (2023). Effects of epidurally administered dexmedetomidine and dexamethasone on postoperative pain, analgesic requirements, inflammation, and oxidative stress in thoracic surgery. Acta Pharmaceutica, 73(4), 691-708. https://doi.org/10.2478/acph-2023-0040
Vancouver
Peršec J, Šribar A, Ilić M, Mamić I, Kifer D, Domijan AM, et al. Effects of epidurally administered dexmedetomidine and dexamethasone on postoperative pain, analgesic requirements, inflammation, and oxidative stress in thoracic surgery. Acta Pharmaceutica. 2023;73(4):691-708. doi:10.2478/acph-2023-0040
BibTeX
@article{Perec2023,
author = {Peršec, Jasminka and Šribar, Andrej and Ilić, Monika and Mamić, Ivan and Kifer, Domagoj and Domijan, Ana-Marija and Maleš, Željan and Turčić, Petra},
title = {Effects of epidurally administered dexmedetomidine and dexamethasone on postoperative pain, analgesic requirements, inflammation, and oxidative stress in thoracic surgery},
journal = {Acta Pharmaceutica},
year = {2023},
volume = {73},
number = {4},
pages = {691--708},
doi = {10.2478/acph-2023-0040}
}
EUVIMED